Personalizing care to optimize outcomes and improve quality of life
We will often recommend a multidisciplinary approach incorporating biological, psychosocial, and cultural treatment practices . The CEO, Dr. Hassamal, is an active research investigator and has extensive experience prescribing cutting edge pharmacotherapeutics, digital technologies, and neuromodulation treatments.
Our team utilizes neuropsychological tests, digital technologies, genetic testing, and biomarker testing to formulate a personalized treatment plan. We integrate the National Institute of Mental Health’s Research Domain Criteria to provide a biologically based treatment framework.
Dysfunction in brain circuits underlies the evolution and progression of neuropsychiatric disorders. We may recommend neuromodulation therapies to restore brain circuitry function.
Inflammation within the brain, also known as neuroinflammation, underpins neuropsychiatric disorders. Dr. Hassamal’s research has identified potential anti-inflammatory treatment pathways. We commonly prescribe anti-inflammatories, hypoglycemic medications, cholesterol lowering agents, and anti-obesity pharmacotherapies to reduce inflammation.
Sign up to hear about updates and breakthrough developments
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.